Similar companies
Income Statement (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 1.8M | 27.6% |
| Gross Profit | 1.8M | 27.6% |
| Operating expense | 19M | 27.7% |
| Net Income | -20M | 36% |
| EBITDA | -18M | 38.2% |
Balance Sheet (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 58M | 7.5% |
| Total Liabilities | 54M | 7% |
| Total Equity | 3.5M | 15.8% |
| Shares Outstanding | 304M | 4.1% |
Cash Flow (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | -13M | 20.4% |
| Cash from investing | -86,000 | 2.3% |
| Cash from financing | 19M | 30244.3% |
EPS
Financial Highlights for Ocugen in Q3 '25
Ocugen reported a revenue of 1.8M, which is a 27.6% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 1.8M, marking a 27.6% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Operating Expenses for this period were 19M, showing a 27.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -20M, showing a -36% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -18M, showing a -38.2% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Ocugen faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
